Steffen Pietzke
CIK 1647008 · Chief Financial Officer · last filed 2023-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.14M
Companies
4
Total Filings
45
Lifetime Open-Market Net
$626.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENVX | Chief Financial Officer | 621,385 | $6.66 | $4.14M | $295.0K | 32 | 2023-07-07 |
| ALXO | VP Fin & Chief Acct Officer | 3,000 | $1.58 | $4.7K | $57.0K | 2 | 2020-07-21 |
| Tricida, Inc. (TCDA) Delisted | VP Fin & Chief Acct Officer | 10,527 | $0.11 | $1.1K | $200.0K | 4 | 2020-02-26 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | VP, Finance and CAO | 160,177 | — | — | $74.9K | 7 | 2017-12-19 |
Recent Filings · Page 4 of 5
45 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-12 | ENVX | Buy (P) | +20,000 | $295.0K | EDGAR |
| 2021-07-16 | ENVX | Grant (A) | — | $0 | EDGAR |
| 2020-07-21 | ALXO | Buy (P) | +3,000 | $57.0K | EDGAR |
| 2020-07-17 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2020-02-26 | Tricida, Inc. (TCDA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-23 | Tricida, Inc. (TCDA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-22 | Tricida, Inc. (TCDA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-02 | Tricida, Inc. (TCDA) Delisted | Buy (P) | +10,527 | $200.0K | EDGAR |
| 2017-12-19 | PDL BIOPHARMA, INC. (PDLI) Delisted | Disp (D) | −5,513 | $0 | EDGAR |
| 2017-03-07 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +98,039 | $200.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.